Morgan Stanley’s 89bio ETNB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | – | Sell |
-444,767
| Closed | -$6.54M | – | 8281 |
|
|
2025
Q3 | $6.54M | Sell |
444,767
-1,740,238
| -80% | -$17.7M | ﹤0.01% | 3925 |
|
|
2025
Q2 | $21.5M | Buy |
2,185,005
+1,555,776
| +247% | +$12.9M | ﹤0.01% | 2736 |
|
|
2025
Q1 | $4.57M | Buy |
629,229
+287,278
| +84% | +$2.51M | ﹤0.01% | 3999 |
|
|
2024
Q4 | $2.67M | Sell |
341,951
-58,287
| -15% | -$480K | ﹤0.01% | 4492 |
|
|
2024
Q3 | $2.96M | Buy |
400,238
+107,793
| +37% | +$906K | ﹤0.01% | 4378 |
|
|
2024
Q2 | $2.34M | Sell |
292,445
-520,177
| -64% | -$4.64M | ﹤0.01% | 4456 |
|
|
2024
Q1 | $9.46M | Sell |
812,622
-2,165,898
| -73% | -$24M | ﹤0.01% | 3392 |
|
|
2023
Q4 | $33.3M | Buy |
2,978,520
+2,378,766
| +397% | +$21.9M | ﹤0.01% | 2872 |
|
|
2023
Q3 | $9.26M | Sell |
599,754
-1,047,262
| -64% | -$17.6M | ﹤0.01% | 3195 |
|
|
2023
Q2 | $31.2M | Buy |
1,647,016
+34,177
| +2% | +$600K | ﹤0.01% | 2023 |
|
|
2023
Q1 | $24.6M | Buy |
1,612,839
+1,507,728
| +1,434% | +$19.7M | ﹤0.01% | 2200 |
|
|
2022
Q4 | $1.34M | Sell |
105,111
-27,254
| -21% | -$245K | ﹤0.01% | 4702 |
|
|
2022
Q3 | $767K | Buy |
132,365
+34,006
| +35% | +$149K | ﹤0.01% | 5040 |
|
|
2022
Q2 | $317K | Buy |
98,359
+28,050
| +40% | +$84.7K | ﹤0.01% | 5652 |
|
|
2022
Q1 | $264K | Buy |
70,309
+31,353
| +80% | +$202K | ﹤0.01% | 5769 |
|
|
2021
Q4 | $509K | Sell |
38,956
-175,428
| -82% | -$2.77M | ﹤0.01% | 5530 |
|
|
2021
Q3 | $4.2M | Sell |
214,384
-16,495
| -7% | -$301K | ﹤0.01% | 3920 |
|
|
2021
Q2 | $4.32M | Sell |
230,879
-107,091
| -32% | -$2.39M | ﹤0.01% | 3933 |
|
|
2021
Q1 | $8M | Sell |
337,970
-98,999
| -23% | -$2.28M | ﹤0.01% | 2881 |
|
|
2020
Q4 | $10.6M | Buy |
436,969
+434,563
| +18,062% | +$11.1M | ﹤0.01% | 2450 |
|
|
2020
Q3 | $62K | Sell |
2,406
-38,218
| -94% | -$1.21M | ﹤0.01% | 5637 |
|
|
2020
Q2 | $809K | Buy |
40,624
+32,070
| +375% | +$779K | ﹤0.01% | 4320 |
|
|
2020
Q1 | $216K | Sell |
8,554
-18,988
| -69% | -$555K | ﹤0.01% | 4831 |
|
|
2019
Q4 | $724K | Buy |
+27,542
| New | +$766K | ﹤0.01% | 4725 |
|
Other funds holding ETNB
Morgan Stanley's ETNB Position: Q4 2025 in Review
Morgan Stanley sold out of 89bio (ETNB) in Q4 2025, closing a stake of 444,767 shares — an estimated $6.54M sold.
Morgan Stanley first reported a position in ETNB in Q4 2019 and held it in 24 quarters. The position peaked at $33.3M in Q4 2023. 2 funds tracked by Wall St. Rank hold ETNB as of Q4 2025.
- Morgan Stanley reported no remaining 89bio position as of Q4 2025 after selling out during the quarter.
- Morgan Stanley sold 444,767 89bio shares in Q4 2025, an estimated $6.54M.
- Morgan Stanley first reported a position in 89bio in Q4 2019 and held it in 24 quarters.
- Morgan Stanley's 89bio position peaked at $33.3M in Q4 2023.
- 2 funds tracked by Wall St. Rank held 89bio as of Q4 2025.
Based on Morgan Stanley's 13F filing for Q4 2025, filed 13 Feb 2026.